Powder: -20°C for 3 years | In solvent: -80°C for 1 year
NUCC-390 dihydrochloride is selective agonist of small-molecule CXCR4 receptor.
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
100 mg | 待询 | 待询 | ||
500 mg | 待询 | 待询 |
NUCC-390 dihydrochloride (1060524-97-1 free base) 的其他形式现货产品:
产品描述 | NUCC-390 dihydrochloride is selective agonist of small-molecule CXCR4 receptor. |
体外活性 | NUCC-390 dihydrochloride (10 μM;?pre-treatment 30 mins) leads to increased levels of pERK, it has the capability of stimulating signaling activity downstream of CXCR4 receptors[1].NUCC-390 (10 μM;?2 hours) can induce CXCR4 receptor internalization, and non-treated cells exhibit some diffuse expression of CXCR4-YFP throughout the cytosol and clear expression in the cell membrane in HEK cells[1]. |
体内活性 | NUCC-390 dihydrochloride?contributes to the functional and anatomical recovery of the neuromuscular junction (NMJ) following an acute nerve terminal damage by α-LTx in CD-1 mice. |
别名 | NUCC-390 dihydrochloride |
分子量 | 468.46 |
分子式 | C23H35Cl2N5O |
CAS No. | T12269L |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
NUCC-390 dihydrochloride (1060524-97-1 free base) T12269L Autophagy GPCR/G Protein Immunology/Inflammation CXCR NUCC390 NUCC-390 Dihydrochloride 1060524-97-1 1060524-97-1 free base NUCC390 Dihydrochloride NUCC-390 dihydrochloride NUCC 390 dihydrochloride (1060524 97 1 free base) NUCC 390 Dihydrochloride NUCC390 dihydrochloride (1060524971 free base) NUCC-390 NUCC 390 Inhibitor inhibitor inhibit